New drugs that lower cholesterol and treat hyperlipidemia are preparing to enter the market.According to The New York Times ...

LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company advancing Lerodalcibep (Lerochol®), a ...

Researchers have discovered that the heartbreaking moment when a person with Alzheimer’s no longer recognizes family may stem ...

The anguish isn't over lost memories, but losing the people we love while still alive. The cruelest Alzheimer's symptom is ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers ...

Stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells can force tumors to ...

Iambic, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced raising over $100 million in an ...

Feeling “tired all the time” seems to have become an inescapable part of modern life, like ubiquitous social media, ...

Tumors were eradicated in 30% of mice receiving cGAS LNPs injected into the tumor, in combination with immune checkpoint blockade.

Second agreement signed with Novartis to develop novel degraders for immune-mediated diseases, providing upfront payment of $120 million plus option maintenance payments, and eligibility for option ...

IBI3016 demonstrates sustained and potent AGT mRNA suppression with preliminary evidence of antihypertensive efficacy after single-dose subcutaneous ...